Hyqvia Infusion: The Monthly Subcutaneous Ig Option That Changed Home Therapy

What if you could get the convenience of subcutaneous immunoglobulin therapy at home — but only infuse once a month instead of every week?

Hyqvia is the only subcutaneous immunoglobulin (SCIg) product that combines human IgG with recombinant hyaluronidase, an enzyme that temporarily opens the tissue under the skin to accept much larger fluid volumes. This unique two-step approach allows patients to infuse their full monthly dose in a single session rather than splitting it across weekly treatments, bridging the gap between the convenience of home SCIg and the monthly schedule of traditional IVIG.

How Hyaluronidase Changes the Game

To understand what makes Hyqvia different, it helps to know why standard subcutaneous immunoglobulin products like Hizentra require weekly infusions. Normally, the tissue just beneath your skin can only absorb a limited amount of fluid at once — roughly 20-40 mL per site. That is why weekly SCIg products use smaller, more frequent doses split across multiple needle sites.

Hyqvia solves this limitation with a clever two-step process. Before the immunoglobulin is infused, a small amount of recombinant hyaluronidase (brand name HYLENEX) is injected under the skin at each infusion site. Hyaluronidase is an enzyme that temporarily breaks down hyaluronic acid — a natural substance that acts like a gel between your cells, holding them together. By briefly loosening this gel, the enzyme creates space for much larger volumes of fluid to be absorbed, up to 300 mL or more per site.

The effect is temporary. Within 24-48 hours, the hyaluronic acid rebuilds and the tissue returns to normal. According to the National Institutes of Health, this mechanism has been studied extensively and has a strong safety record.

The Hyqvia Infusion Process

A Hyqvia infusion takes longer than a weekly Hizentra session — typically 2-4 hours — but you only do it once a month. Here is how it works:

1. Prepare both components. Hyqvia comes as two separate vials: the hyaluronidase (HYLENEX) and the immunoglobulin (10% IgG). Let both reach room temperature.
2. Infuse the hyaluronidase first. Using a small needle placed under the skin (usually in the abdomen or thigh), the hyaluronidase is pushed in over about 1-2 minutes per site. Most patients use 1-2 sites.
3. Wait briefly. Allow about 10 minutes for the enzyme to begin working.
4. Infuse the immunoglobulin. Through the same needle site(s), the IgG is infused using a pump. The rate starts slowly and is gradually increased as tolerated.
5. Remove needles and rest. After the infusion, the site may appear temporarily swollen — this is normal. The fluid absorbs over the next several hours.

The FDA approved Hyqvia for adults with primary immunodeficiency (PI). It is not currently approved for CIDP, though research continues.

Hyqvia vs. Hizentra: Head-to-Head Comparison

Patients considering subcutaneous immunoglobulin therapy often want to know how these two products stack up. Here is a direct comparison:

Neither product is universally “better.” The right choice depends on your preferences, schedule, diagnosis, and how your body responds. Some patients prefer the smaller, more frequent Hizentra infusions because each session is quick and causes minimal site swelling. Others strongly prefer Hyqvia’s once-monthly approach because it frees up three to four weeks entirely.

Side Effects to Know About

Because Hyqvia delivers a larger volume of fluid at once, the side effect profile is slightly different from weekly SCIg products. According to Cleveland Clinic, common side effects include:

• Local site reactions: Swelling, redness, and mild tenderness at the infusion site. The swelling can be more noticeable than with Hizentra because of the larger volume, but it typically resolves within 1-2 days.
• Headache: Occurs in some patients, particularly during the first few infusions.
• Fatigue: Some patients feel tired for a day or two after infusion.
• Nausea: Mild and usually temporary.

The local swelling is the most frequently discussed side effect among patients. After a Hyqvia infusion, the area where the fluid was delivered may look puffy or feel like a “bump” under the skin. This is the immunoglobulin being slowly absorbed — it is not a sign of a problem. Most patients find that the swelling goes down significantly within 24 hours and completely within 48 hours.

Who Is a Good Candidate for Hyqvia?

Hyqvia tends to work well for patients who:

• Have primary immunodeficiency and are already stable on immunoglobulin therapy
• Prefer fewer infusion days — once a month rather than weekly
• Are comfortable with a longer individual session in exchange for fewer total sessions
• Want to reduce the number of needle sticks per month
• Have been on IVIG and want to transition to home therapy without the weekly commitment

Patients who may not be ideal candidates include those with very limited subcutaneous tissue, those who had reactions to hyaluronidase in the past, or children (Hyqvia is currently approved only for adults). If you are exploring the transition from intravenous to subcutaneous therapy, see Switching from IVIG to SCIg for what to expect.

Cost and Insurance

Hyqvia’s cost is comparable to other immunoglobulin products — and that means it is expensive. Monthly costs can range from $5,000 to $15,000 or more before insurance, depending on the dose. The hyaluronidase component adds to the overall cost compared to standard SCIg products.

The good news is that most insurance plans cover Hyqvia for FDA-approved indications with prior authorization. The manufacturer (Takeda) offers patient support programs that can help with copays and access. If cost is a barrier, see the guide on IVIG insurance coverage for strategies that apply to all immunoglobulin products, including Hyqvia.

Questions to Ask Your Doctor

If Hyqvia interests you, consider bringing these questions to your next appointment:

• Am I a candidate for Hyqvia based on my diagnosis and current treatment?
• How would the transition from my current therapy work?
• What should I expect with the hyaluronidase injection — will it hurt?
• Will my insurance cover Hyqvia, and who can help with prior authorization?
• How does my current IgG level stability factor into the decision?

Remember: the best immunoglobulin product is the one that fits your life while keeping your levels where they need to be. There is no one-size-fits-all answer, and it is entirely reasonable to try one product and switch to another if it is not working for you.